Stock Events

Cardio Diagnostics 

$0.47
34
+$0+0.3% Friday 19:52

Statistics

Day High
-
Day Low
-
52W High
3.56
52W Low
0.17
Volume
20,051
Avg. Volume
178,986
Mkt Cap
10.66M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

7NovConfirmed
Q3 2021
Q1 2022
Q2 2022
Q3 2022
-0.66
-0.43
-0.21
0.02
Expected EPS
-0.66
Actual EPS
0.02

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CDIO. It's not an investment recommendation.
Alphabet
68918
GOOGL
Apple
60554
AAPL
Microsoft
56693
MSFT
Amazon
51850
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap177.49B
Abbott Laboratories offers a broad range of diagnostics products, including cardiovascular diagnostics, competing directly with Cardio Diagnostics' offerings.
Quest Diagnostics
DGX
Mkt Cap16.22B
Quest Diagnostics provides diagnostic testing for conditions including heart diseases, making it a competitor in the cardiovascular diagnostics market.
Thermo Fisher Scientific
TMO
Mkt Cap203.97B
Thermo Fisher Scientific offers products and services for diagnostics, including cardiovascular health, competing in the same space as Cardio Diagnostics.
Bio-Rad Laboratories
BIO
Mkt Cap8.45B
Bio-Rad Laboratories provides clinical diagnostics products, including those for cardiovascular disease, directly competing with Cardio Diagnostics.
Danaher
DHR
Mkt Cap180.39B
Danaher Corporation's diagnostics segment includes products for cardiovascular health, making it a competitor to Cardio Diagnostics.
Labcorp
LH
Mkt Cap0
Laboratory Corporation of America offers a range of diagnostic tests, including for cardiovascular conditions, competing with Cardio Diagnostics.
Boston Scientific
BSX
Mkt Cap114.03B
Boston Scientific Corporation specializes in medical devices for conditions including heart diseases, indirectly competing with Cardio Diagnostics by offering alternative diagnostic solutions.
Medtronic
MDT
Mkt Cap101.91B
Medtronic plc offers medical devices for diagnosing and treating heart conditions, providing an alternative approach to Cardio Diagnostics' solutions.
Hologic
HOLX
Mkt Cap18.23B
Hologic, Inc. provides diagnostics products and services, including for cardiovascular health, making it a competitor in the diagnostics market.
Agilent Technologies
A
Mkt Cap38.45B
Agilent Technologies provides laboratories worldwide with instruments, services, consumables, applications, and expertise, including in cardiovascular diagnostics, competing with Cardio Diagnostics.

Analyst Ratings

2$Average Price Target
The highest estimate is $2.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

About

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Show more...
CEO
Employees
7
Country
US
ISIN
US14159C1036

Listings

XNAS
US
CDIO
XNAS
US
CDIOW